MDxHealth (MDxHealth) Debt-to-Equity : 2.28 (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is MDxHealth Debt-to-Equity?

MDxHealth's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $2.04 Mil. MDxHealth's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was $38.70 Mil. MDxHealth's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $17.84 Mil. MDxHealth's debt to equity for the quarter that ended in Sep. 2023 was 2.28.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for MDxHealth's Debt-to-Equity or its related term are showing as below:

MDXH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.41 Max: 4.27
Current: 2.28

During the past 13 years, the highest Debt-to-Equity Ratio of MDxHealth was 4.27. The lowest was 0.01. And the median was 0.41.

MDXH's Debt-to-Equity is ranked worse than
95.94% of 197 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs MDXH: 2.28

MDxHealth Debt-to-Equity Historical Data

The historical data trend for MDxHealth's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MDxHealth Debt-to-Equity Chart

MDxHealth Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.56

2.71

0.33

4.27

MDxHealth Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															1.78	4.27	1.05	1.52	2.28

Competitive Comparison of MDxHealth's Debt-to-Equity

For the Diagnostics & Research subindustry, MDxHealth's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MDxHealth's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, MDxHealth's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where MDxHealth's Debt-to-Equity falls into.

MDxHealth Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

MDxHealth's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.788	+	38.005)	/	9.315
	=	4.27

MDxHealth's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.036	+	38.696)	/	17.844
	=	2.28

MDxHealth (NAS:MDXH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

MDxHealth Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of MDxHealth's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MDxHealth (MDxHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » Debt-to-Equity

Comparable Companies

BIOQ PSNL VNRX PRE ENZ PRPH ACRS BNR DRIO AWH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

N/A

Address

Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040

Website

https://www.mdxhealth.com

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.